![N-{5-[(1R)-1-hydroxyethyl]-1,3-thiazol-2-yl}-alpha-D-mannopyranosylamine in PDB entry 3zl1, assembly 2, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3zl1_entity_2_side_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>3zl1</span> contains 1 copy of <span class='highlight'>N-{5-[(1R)-1-hydroxyethyl]-1,3-thiazol-2-yl}-alpha-D-mannopyranosylamine</span>. Side view.")
![N-{5-[(1R)-1-hydroxyethyl]-1,3-thiazol-2-yl}-alpha-D-mannopyranosylamine in PDB entry 3zl1, assembly 2, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3zl1_entity_2_top_image-200x200.png "Monomeric assembly 2 of PDB entry <span class='highlight'>3zl1</span> contains 1 copy of <span class='highlight'>N-{5-[(1R)-1-hydroxyethyl]-1,3-thiazol-2-yl}-alpha-D-mannopyranosylamine</span>. Top view.")
Environment details NEW
BWG 1159 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.